Cocaine Use Disorders Completed Phase 1 Trials for Methylphenidate (DB00422)

Also known as: Cocaine Use Disorder

IndicationStatusPhase
DBCOND0032361 (Cocaine Use Disorders)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02700711Methylphenidate-Duloxetine Combinations for Cocaine DependenceBasic Science